Stock Screener App

無料 -

インストール

1.92

3.03% -0.06

after-market

アフターアワーズ： 1.94 0.02 +1.04%

Serina Therapeutics Inc (SER)

概要ニュース株価時系列ディスカッション予測

Serina Therapeutics Inc (SER) 最新ニュース

Serina Therapeutics director Karen Wilson buys $37,000 in shares By Investing.com - Investing.com Australia

Director boosts stake in Serina Therapeutics (SER) with 20K-share buy - Stock Titan

Serina Therapeutics Inc (SER) Q1 2026 Earnings: EPS Miss Amid Continued Development ProgressFinancial Summary - Newser

Serina Therapeutics Q1 2026 Earnings: EPS Misses Estimates as Stock Climbs Despite LossGAAP Earnings Report - Newser

Serina Therapeutics Inc. (SER) Recovers 4.93% as Stock Approaches Key Resistance at $2.08Volume Spike Alerts - Newser

Serina Therapeutics Inc. (SER) Gains Nearly 5% as Stock Approaches Key ResistanceTop Analyst Buy Signals - Newser

Director at Serina Therapeutics (SER) makes open-market buy of 12,183 shares - Stock Titan

16.45M Serina shares registered for resale (NYSE: SER) - Stock Titan

Serina Therapeutics : Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi - marketscreener.com

SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

Serina Therapeutics (SER) Gets a Buy from JonesTrading - The Globe and Mail

Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks - The Globe and Mail

Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN

Serina Therapeutics 1Q Loss/Shr 58c >SER - Moomoo

Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times

Parkinson's drug trial moves ahead as Serina adds $21.2M funding - Stock Titan

Serina Therapeutics (NYSE: SER) raises $21.2M and advances SER-252 trial - Stock Titan

Serina Therapeutics (NYSE: SER) posts Q1 loss and raises $21.2M PIPE amid cash risk - Stock Titan

Serina Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

SER Technical Analysis | Trend, Signals & Chart Patterns | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

MSN Money - MSN

TradingKey - TradingKey

What Serina Therapeutics (SER) is doing to stay ahead (Slight Loss) 2026-05-08Social Trade Signals - newser.com

How Serina Therapeutics (SER) responds when competition intensifies (Volatility Increases) 2026-05-08Community Buy Alerts - newser.com

The recurring revenue story behind Serina Therapeutics (SER) | Q4 2025: EPS Exceeds ExpectationsPut/Call Ratio - newser.com

Sio Capital (SER) reports 1,000,000 shares, 6.71% stake in Serina Therapeutics - Stock Titan

Serina Therapeutics (SER) Stock: Is It a Strong Investment Pick | Q4 2025: Earnings Beat EstimatesTrending Entry Points - newser.com

Chart Pattern Insight | Serina Therapeutics notches 33% EPS beat, tops loss estimatesPost Earnings - newser.com

Serina Therapeutics (NYSE: SER) seeks share increase and equity plan changes in 2026 proxy - Stock Titan

ROIV

$29.66

0.98%

BNTX

$92.25

0.12%

INSM

$108.87

2.48%

RPRX

$53.86

1.17%

ONC

$302.44

2.52%

RVMD

$154.89

2.20%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | ロイターで開く